van Rijn RM - Search Results

1

Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.

Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R. Lim HD, et al. Among authors: van rijn rm. J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21. doi: 10.1124/jpet.105.087965. Epub 2005 Jun 9. J Pharmacol Exp Ther. 2005. PMID: 15947036

2

Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.

Terzioglu N, van Rijn RM, Bakker RA, De Esch IJ, Leurs R. Terzioglu N, et al. Among authors: van rijn rm. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5251-6. doi: 10.1016/j.bmcl.2004.08.035. Bioorg Med Chem Lett. 2004. PMID: 15454206

3

Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms.

Bakker RA, Lozada AF, van Marle A, Shenton FC, Drutel G, Karlstedt K, Hoffmann M, Lintunen M, Yamamoto Y, van Rijn RM, Chazot PL, Panula P, Leurs R. Bakker RA, et al. Among authors: van rijn rm, van marle a. Mol Pharmacol. 2006 Apr;69(4):1194-206. doi: 10.1124/mol.105.019299. Epub 2006 Jan 13. Mol Pharmacol. 2006. PMID: 16415177

4

Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors.

van Rijn RM, Chazot PL, Shenton FC, Sansuk K, Bakker RA, Leurs R. van Rijn RM, et al. Mol Pharmacol. 2006 Aug;70(2):604-15. doi: 10.1124/mol.105.020818. Epub 2006 Apr 27. Mol Pharmacol. 2006. PMID: 16645125

5

Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor.

van Rijn RM, van Marle A, Chazot PL, Langemeijer E, Qin Y, Shenton FC, Lim HD, Zuiderveld OP, Sansuk K, Dy M, Smit MJ, Tensen CP, Bakker RA, Leurs R. van Rijn RM, et al. Among authors: van marle a. Biochem J. 2008 Aug 15;414(1):121-31. doi: 10.1042/BJ20071583. Biochem J. 2008. PMID: 18452403

6

Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype.

Meqbil YJ, Aguilar J, Blaine AT, Chen L, Cassell RJ, Pradhan AA, van Rijn RM. Meqbil YJ, et al. Among authors: van rijn rm. J Pharmacol Exp Ther. 2024 May 21;389(3):301-309. doi: 10.1124/jpet.123.001735. J Pharmacol Exp Ther. 2024. PMID: 38621994

7

Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.

van Rijn RM, Brissett DI, Whistler JL. van Rijn RM, et al. J Pharmacol Exp Ther. 2010 Oct;335(1):133-9. doi: 10.1124/jpet.110.170969. Epub 2010 Jul 6. J Pharmacol Exp Ther. 2010. PMID: 20605909 Free PMC article.

8

Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling.

van Rijn RM, Harvey JH, Brissett DI, DeFriel JN, Whistler JL. van Rijn RM, et al. J Pharmacol Exp Ther. 2013 Jan;344(1):179-88. doi: 10.1124/jpet.112.198655. Epub 2012 Oct 24. J Pharmacol Exp Ther. 2013. PMID: 23097213 Free PMC article.

9

β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake.

Chiang T, Sansuk K, van Rijn RM. Chiang T, et al. Among authors: van rijn rm. Br J Pharmacol. 2016 Jan;173(2):332-43. doi: 10.1111/bph.13374. Br J Pharmacol. 2016. PMID: 26507558 Free PMC article.

10

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.

Mores KL, Cummins BR, Cassell RJ, van Rijn RM. Mores KL, et al. Among authors: van rijn rm. Front Pharmacol. 2019 Apr 17;10:407. doi: 10.3389/fphar.2019.00407. eCollection 2019. Front Pharmacol. 2019. PMID: 31057409 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters